A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancerCULLEN, M. H; ZATLOUKAL, P; SÖRENSON, S et al.Annals of oncology. 2008, Vol 19, Num 5, pp 939-945, issn 0923-7534, 7 p.Article

Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagusALLEN, S. M; DUFFY, J. P; DARNTON, S. J et al.Cancer chemotherapy and pharmacology. 1996, Vol 37, Num 5, pp 496-498, issn 0344-5704Article

A phase II study on mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagusALLEN, S. M; DUFFY, J. P; WALKER, S. J et al.Clinical oncology (Springer. Print). 1994, Vol 6, Num 2, pp 91-95, issn 0936-6555Article

Advances in the management of cytotoxic drug-induced nausea and vomitingFREEMAN, A. J; CULLEN, M. H.Journal of clinical pharmacy and therapeutics (Print). 1991, Vol 16, Num 6, pp 411-421, issn 0269-4727Article

Treatment of oesophageal small cell carcinoma by combined chemotherapy and surgical resection: report of two cases and review of published casesWALKER, S. J; STEEL, A; CULLEN, M. H et al.Thorax. 1989, Vol 44, Num 9, pp 751-752, issn 0040-6376, 2 p.Article

A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphomaBESSELL, E. M; BURTON, A; JONES, E. L et al.Annals of oncology. 2003, Vol 14, Num 2, pp 258-267, issn 0923-7534, 10 p.Article

Primary chemotherapy after orchidectomy for stage I and II nonseminoma : Germ cell tumorsHORWICH, A; CULLEN, M. H; STENNING, S. P et al.Seminars in oncology. 1998, Vol 25, Num 2, pp 154-159, issn 0093-7754Article

A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma NHLSMITH, G. M; CHILD, J. A; CULLEN, M. H et al.Hematological oncology. 1996, Vol 14, Num 4, pp 193-201, issn 0278-0232Article

Long-term toxicity of chemotherapy for testicular cancer : the cost of cureSTUART, N. S. A; WOODROFFE, C. M; GRUNDY, R et al.British journal of cancer. 1990, Vol 61, Num 3, pp 479-484, issn 0007-0920, 6 p.Article

A new approach to the treatment of advanced high-grade non-Hodgkin's lymphoma-intensive two-phase chemotherapySTUART, N. S. A; BLACKLEDGE, G. R. P; MACLENNAN, I. C. M et al.Cancer chemotherapy and pharmacology. 1988, Vol 22, Num 2, pp 141-146, issn 0344-5704Article

Chemotherapy for poor risk germ cell tumours: an independent evaluation of the POMB/ACE regimeCULLEN, M. H; HARPER, P. G; WOODROFFE, C. M et al.British journal of urology (Print). 1988, Vol 62, Num 5, pp 454-460, issn 0007-1331, 7 p.Article

Management of febrile neutropenia: ESMO Clinical Practice GuidelinesDE NAUROIS, J; NOVITZKY-BASSO, I; GILL, M. J et al.Annals of oncology. 2010, Vol 21, issn 0923-7534, v252-v256, SUP5Article

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours : a prospective trial (MRC TE17)DEARNALEY, D. P; FOSSA, S. D; COOK, P. A et al.British journal of cancer. 2005, Vol 92, Num 12, pp 2107-2113, issn 0007-0920, 7 p.Article

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer : Effects on survival and quality of lifeCULLEN, M. H; BILLINGHAM, L. J; TRASK, C et al.Journal of clinical oncology. 1999, Vol 17, Num 10, pp 3188-3194, issn 0732-183XArticle

A Phase II trial of preoperative mitomycin, cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagusDARNTON, S. J; FERRY, D. R; CULLEN, M. H et al.Clinical oncology (Springer. Print). 1998, Vol 10, Num 6, pp 372-376, issn 0936-6555Article

Radiotherapy after chemotherapy for metastatic seminoma : a diminishing roleDUCHESNE, G. M; STENNING, S. P; CULLEN, M. H et al.European journal of cancer (1990). 1997, Vol 33, Num 6, pp 829-835, issn 0959-8049Article

Adjuvant and neo-adjuvant chemotherapy in non-small cell carcinoma. DiscussionCULLEN, M. H; SMITH, I; THATCHER, N et al.Annals of oncology. 1995, Vol 6, pp S43-S48, issn 0923-7534, SUP1Conference Paper

Ifosfamide, mitomycin and radiotherapy in non-small-cell lung cancerCHETIYAWARDANA, S. D; CULLEN, M. H; JOSHI, R. C et al.Cancer chemotherapy and pharmacology. 1989, Vol 24, Num 2, pp 102-104, issn 0344-5704Article

The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trialO'BRIEN, M. E. R; CULLEN, M. H; WOODROFFE, C et al.British journal of cancer. 1989, Vol 60, Num 5, pp 759-763, issn 0007-0920Article

A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancerSTUART, N. S. A; CULLEN, M. H; PRIESTMAN, T. J et al.Cancer chemotherapy and pharmacology. 1988, Vol 21, Num 4, pp 351-354, issn 0344-5704Article

Combined granulocyte and platelet transfusions: inter-relationship between granulocyte and platelet recoveries in the presence and absence of complicating factorsFORD, J. M; CULLEN, M. H; BROWN, L. M et al.Scandinavian journal of haematology. 1984, Vol 32, Num 1, pp 65-75, issn 0036-553XArticle

Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancerBILLINGHAM, L. J; BATHERS, S; BURTON, A et al.Lung cancer. 2002, Vol 37, Num 2, pp 219-225, issn 0169-5002Article

The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer. EditorialBILLINGHAM, L. J; CULLEN, M. H; ROSELL, R et al.Annals of oncology. 2001, Vol 12, Num 12, pp 1659-1661, issn 0923-7534, 8 p.Article

A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminomaHORWICH, A; OLIVER, R. T. D; STENNING, S. P et al.British journal of cancer. 2000, Vol 83, Num 12, pp 1623-1629, issn 0007-0920Article

Page / 2